Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,930 public trials 461 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Active, Not Recruiting

A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis

NCT06551519

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Novartis Investigative Site Albstadt, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Hettingen, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Mannheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Schwetzingen, Baden-Wurttemberg, Germany
View all 89 locations
View Trial Details
Active, Not Recruiting

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

NCT04688788

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • Danish Multiple Sclerosis Center, Rigshospitalet Glostrup Municipality, Copenhagen, Denmark
  • Department of Neurology, Aalborg University Hospital Aalborg, Denmark
  • Department of Neurology, Aarhus University Hospital Aarhus, Denmark
  • Department of Neurology, Hospital of South West Jutland, Esbjerg Esbjerg, Denmark
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

NCT01892722

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Body Weight, +8 more
Locations
  • UAB Childrens Hospital Harbor Center Neurology Dept Birmingham, Alabama, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • University of Miami Miami, Florida, United States
View all 73 locations
View Trial Details
Active, Not Recruiting

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

NCT05090371

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations
  • Alabama Neurology Associates PC Birmingham, Alabama, United States
  • North Central Neurology Associates PC Cullman, Alabama, United States
  • Radiant Research Chandler Chandler, Arizona, United States
  • Arizona Neuroscience Research LLC Phoenix, Arizona, United States
View all 43 locations
View Trial Details

Related conditions